Weekly administration of paclitaxel: theoretical and clinical basis
- 21 December 2002
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 44, 3-13
- https://doi.org/10.1016/s1040-8428(02)00109-9
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Interim analysis of a phase II study of induction weekly paclitaxel/carboplatin regimens followed by maintenance weekly paclitaxel for advanced and metastatic non-small cell lung cancerSeminars in Oncology, 2001
- Weekly paclitaxel in advanced non[ndash ]small cell lung cancerSeminars in Oncology, 2001
- Interaction between Herceptin® and TaxanesOncology, 2001
- Second-line (SL) weekly paclitaxel (P) in patients (pts) with advanced non-small cell lung cancer (NSCLC) failing first-line (FL) carboplatin/paclitaxel (C/P)Lung Cancer, 2000
- Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.Journal of Clinical Investigation, 1997
- Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of PaclitaxelJNCI Journal of the National Cancer Institute, 1996
- Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancerEuropean Journal Of Cancer, 1996
- Removal of MAP4 from microtubules in vivo produces no observable phenotype at the cellular level.The Journal of cell biology, 1996
- MicrotubulesScientific American, 1980
- Characterization of microtubule assembly in porcine brain extracts by viscometryBiochemistry, 1973